Researchers at MIT developed a non-invasive method for measuring blood glucose levels, potentially offering an alternative to fingersticks. Many people with diabetes today use continuous glucose monitors (CGMs) to keep track of their glucose levels. Those devices still have a small, minimally invasive interstitial needle inserted into the body when applied and don’t exceed a […]
Patient Monitoring
Dexcom launches program to enhance healthcare provider CGM knowledge
Dexcom (Nasdaq:DXCM) today announced the launch of Dexcom Academy, a new, personalized learning platform for healthcare professionals (HCPs). Guided by HCP insights, the company designed Dexcom Academy to strengthen confidence in continuous glucose monitor (CGM) use. The San Diego-based CGM maker wants to support consistent, high-quality diabetes care without adding to clinical burden. The company […]
Insulet makes Omnipod 5 available with Dexcom G7 15 Day CGM
Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom (Nasdaq:DXCM) G7 15 Day CGM. Acton, Massachusetts-based Insulet, which has paired its pumps with previous versions of Dexcom continuous glucose monitors (CGMs), has offered Omnipod 5 with the initial version of G7 since early 2024. However, Dexcom received FDA clearance for people […]
Medtronic begins full commercial rollout of MiniMed 780G with Instinct sensor made by Abbott
Medtronic (NYSE:MDT) today announced the full U.S. launch for its Instinct sensor, made by Abbott, paired with the MiniMed 780G pump. The medtech giant’s diabetes unit — one of the largest diabetes tech businesses in the world — won FDA clearance for its SmartGuard algorithm as an interoperable automated glycemic controller (iAGC) earlier this year, enabling […]
PreEvnt brings non-invasive glucose alert device to clinical trials
PreEvnt announced today that its Isaac non-invasive glucose monitoring system has entered clinical trials. Under the direction of Dr. Mangilal Agarwal, the device entered trials at Indiana University, Indianapolis. The study marks a step forward in validating Isaac’s potential as a tool for managing diabetes through breath-based measurements. The current phase of research includes adolescents […]
Abbott initiates correction for FreeStyle Libre 3, Libre 3 Plus CGMs after reports of deaths
Abbott (NYSE:ABT) announced today that it issued a medical device correction for certain FreeStyle Libre 3 and Libre 3 Plus sensors in the U.S. This correction comes as a result of an issue that led to hundreds of severe adverse events, including seven deaths. Abbott — one of the largest diabetes tech companies in the world — […]
Dexcom to launch G7 15 Day CGM next month
Dexcom (NSDQ:DXCM) announced today that it plans to launch its G7 15 Day continuous glucose monitor (CGM) in the U.S. next month. The San Diego–based company plans to make the CGM available for people over the age of 18 with diabetes on Dec. 1. Initially, the company plans to make the sensor available for users […]
Dexcom wins FDA nod for smart CGM-integrated basal dosing for type 2 diabetes
Dexcom (NSDQ:DXCM) announced today that the FDA cleared its Smart Basal CGM-integrated basal insulin dosing optimizer. The continuous glucose monitor (CGM)-based offering received clearance for adults with type 2 diabetes on glargine U-100 long-acting insulin therapy. San Diego-based Dexcom says it marks the first and only CGM-integrated basal dosing optimizer cleared for type 2 diabetes. […]
Medtronic Diabetes to submit patch pump to FDA by fall 2026, separation remains on track
Medtronic officials today said the planned separation of its Diabetes business (MiniMed) remains on track, with future offerings also on the horizon. On the company’s second-quarter earnings call, CFO Thierry Piéton outlined the expected timelines for the Diabetes business, following another quarter of significant growth. Global Diabetes revenues grew 10.3% year over year, despite a […]
What diabetes tech companies are doing on World Diabetes Day 2025
Once again, World Diabetes Day, celebrated on Nov. 14 every year, has come around, highlighting new initiatives in the diabetes tech space. The date marks the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. It also lands during the American Diabetes Association’s National Diabetes Awareness Month. […]
